[Letter: Evaluation of Colfarit].
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control
D000925:Anticoagulants; D001241:Aspirin
Zur Beurteilung von Colfarit.